Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Active not recruiting 6Recruiting 3Not yet recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 76Bevacizumab 66Drug Therapy 64Cisplatin 64Carboplatin 63Magnetic Resonance Spectroscopy 59Radiotherapy 57pembrolizumab 54Gemcitabine 54Cyclophosphamide 54Capecitabine 51Oxaliplatin 50toripalimab 44Paclitaxel 41tislelizumab 40Standard of Care 39fludarabine 36Fluorouracil 35Injections 34Biopsy 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 29Surgical Procedures, Operative 28Nivolumab 28Irinotecan 27Docetaxel 27Dexamethasone 27Leucovorin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Losartan × 1 year × Clear all
NCT07265739 2026-05-06

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Massachusetts General Hospital

Phase 2 Not yet recruiting
27 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT07160361 2025-09-16

Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB

Second Affiliated Hospital of Xi'an Jiaotong University

Phase 4 Not yet recruiting
56 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡